David Dahlgren
Impact in
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 30
- Drug Transport and Resistance Mechanisms 22
- Neutropenia and Cancer Infections 5
-
- Drug Solubulity and Delivery Systems 19
- Advanced Drug Delivery Systems 17
- Co-authors
- Hans Lennernäs (40 shared papers)Erik Sjögren (17 shared papers)Markus Sjöblom (23 shared papers)Carl Roos (8 shared papers)Christer Tannergren (9 shared papers)Per M. Hellström (8 shared papers)Anders Lundqvist (7 shared papers)Christian Roos (7 shared papers)
- Journals
- European Journal of Pharmaceutics and Biopharmaceutics (9 papers)Molecular Pharmaceutics (6 papers)Pharmaceutics (5 papers)International Journal of Molecular Sciences (4 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- SwedenGermanyUnited States
In The Last Decade
David Dahlgren
44 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 102
- Pharmaceutical Science 528
- Oncology 413
- Gastroenterology 64
- Pharmacology 72
- Otorhinolaryngology 30
Countries citing papers authored by David Dahlgren
This map shows the geographic impact of David Dahlgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dahlgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dahlgren more than expected).
Fields of papers citing papers by David Dahlgren
This network shows the impact of papers produced by David Dahlgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dahlgren. The network helps show where David Dahlgren may publish in the future.
Co-authors
The 25 scholars most cited alongside David Dahlgren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 182 | |
| 2 | 2014 | 94 | |
| 3 | 2021 | 94 | |
| 4 | 2015 | 58 | |
| 5 | 2016 | 58 | |
| 6 | 2017 | 54 | |
| 7 | 2023 | 50 | |
| 8 | 2021 | 48 | |
| 9 | 2018 | 45 | |
| 10 | 2017 | 44 | |
| 11 | 2016 | 34 | |
| 12 | 2019 | 32 | |
| 13 | 2017 | 31 | |
| 14 | 2018 | 30 | |
| 15 | 2021 | 26 | |
| 16 | 2018 | 25 | |
| 17 | 2020 | 22 | |
| 18 | 2018 | 22 | |
| 19 | 2018 | 22 | |
| 20 | 2019 | 22 |
About David Dahlgren
David Dahlgren is a scholar working on Oncology, Pharmaceutical Science, Pulmonary and Respiratory Medicine, Molecular Biology and Gastroenterology, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (22 papers), Drug Solubulity and Delivery Systems (19 papers), Advanced Drug Delivery Systems (17 papers), Oral health in cancer treatment (7 papers), Gastrointestinal motility and disorders (5 papers), Neutropenia and Cancer Infections (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Pharmaceutical Science (528 citations), Oncology (413 citations), Gastroenterology (64 citations), Pharmacology (72 citations) and Otorhinolaryngology (30 citations). David Dahlgren has collaborated with scholars based in Sweden, Germany and United States. Frequent co-authors include Hans Lennernäs, Erik Sjögren, Markus Sjöblom, Carl Roos, Christer Tannergren, Per M. Hellström, Anders Lundqvist, Christian Roos, Bertil Abrahamsson and Mikael Hedeland. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, Molecular Pharmaceutics, Pharmaceutics, International Journal of Molecular Sciences and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.